Levine M - Search Results

1

Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.

Morton M, Marcu I, Levine M, Cosgrove C, Backes F, O'Malley D, Chambers L. Morton M, et al. Among authors: levine m. Obstet Gynecol. 2023 Aug 1;142(2):360-363. doi: 10.1097/AOG.0000000000005243. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37411031

2

Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study.

Levine MD, Pearlman R, Hampel H, Cosgrove C, Cohn D, Chassen A, Suarez A, Barrington DA, McElroy JP, Waggoner S, Nakayama J, Billingsley C, Resnick K, Andrews S, Singh S, Jenison E, Clements A, Neff R, Goodfellow PJ; Ohio Prevention and Treatment of Endometrial Cancer Initiative Study Group. Levine MD, et al. JCO Precis Oncol. 2021 Nov;5:1588-1602. doi: 10.1200/PO.21.00249. JCO Precis Oncol. 2021. PMID: 34994648 Free PMC article.

3

Postoperative venous thromboembolism risk stratification in patients with uterine cancer.

Wagner VM, Piver RN, Levine MD, Backes FJ, Chambers LJ, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Bixel KL. Wagner VM, et al. Among authors: levine md. Am J Obstet Gynecol. 2023 May;228(5):555.e1-555.e8. doi: 10.1016/j.ajog.2022.12.310. Epub 2022 Dec 24. Am J Obstet Gynecol. 2023. PMID: 36574873

4

The modified 5-item frailty index is a predictor of post-operative complications in vulvar cancer: a National Surgical Quality Improvement Program (NSQIP) analysis.

Levine MD, Felix AS, Meade CE, Bixel KL, Chambers LM. Levine MD, et al. Int J Gynecol Cancer. 2023 Apr 3;33(4):465-472. doi: 10.1136/ijgc-2022-004175. Int J Gynecol Cancer. 2023. PMID: 36898698

5

Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer.

Piver RN, Wagner VM, Levine MD, Backes FJ, Chambers LJ, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Bixel KL. Piver RN, et al. Among authors: levine md. Gynecol Oncol Rep. 2023 Feb 28;46:101156. doi: 10.1016/j.gore.2023.101156. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 36910448 Free PMC article.

6

Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.

Levine MD, Barrington DA, Meade CE, Lammers SM, McLaughlin EM, Suarez AA, Backes FJ, Copeland LJ, O'Malley DM, Cosgrove CM, Cohn DE, Nagel CI, Felix AS, Bixel KL. Levine MD, et al. Gynecol Oncol. 2023 Jun;173:15-21. doi: 10.1016/j.ygyno.2023.03.023. Epub 2023 Apr 8. Gynecol Oncol. 2023. PMID: 37037083

7

Combination lenvatinib plus pembrolizumab in the treatment of ovarian clear cell carcinoma: A case series.

Calo CA, Levine MD, Brown MD, O'Malley DM, Backes FJ. Calo CA, et al. Among authors: levine md. Gynecol Oncol Rep. 2023 Mar 31;46:101171. doi: 10.1016/j.gore.2023.101171. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 37065539 Free PMC article.

8

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Levine MD, O'Malley DM, Haight PJ, Senter L, Wagner V, Bixel KL, Cohn DE, Copeland LJ, Cosgrove CM, McLaughlin EM, Backes FJ. Levine MD, et al. Gynecol Oncol Rep. 2023 Mar 31;46:101173. doi: 10.1016/j.gore.2023.101173. eCollection 2023 Apr. Gynecol Oncol Rep. 2023. PMID: 37082521 Free PMC article.

9

Gastritis as an immunotherapy-related toxicity in the treatment of endometrial cancer: A case report.

Goel N, Levine MD, Chambers LM, Nagel CI. Goel N, et al. Among authors: levine md. Gynecol Oncol Rep. 2023 Mar 31;47:101174. doi: 10.1016/j.gore.2023.101174. eCollection 2023 Jun. Gynecol Oncol Rep. 2023. PMID: 37102082 Free PMC article.

10

Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.

Levine MD, Wang H, Sriram B, Khan A, Senter L, McLaughlin EM, Bixel KL, Chambers LM, Cohn DE, Copeland LJ, Cosgrove CM, Nagel CI, O'Malley DM, Backes FJ. Levine MD, et al. Gynecol Oncol. 2024 Mar;182:51-56. doi: 10.1016/j.ygyno.2023.12.008. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,462 results

Search Page